Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SMC1 involvement in fragile site expression.

Antonio Musio1, Cristina Montagna, Tullio Mariani

  • 1Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Via Fratelli Cervi, 93, 20090 Segrate, Milan, Italy. antonio.musio@itb.cnr.it

Human Molecular Genetics
|January 11, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct probabilistic quantification of mosaic loss of chromosome Y from sequencing data.

bioRxiv : the preprint server for biology·2026
Same author

Dual actionability of BMI1 activation and mitotic vulnerability defines adaptive Osimertinib resistance in EGFR-mutant NSCLC.

Cell death & disease·2026
Same author

Mutation type-specific transcriptomic signatures and readthrough therapy rescue in SMC1A-related developmental and epileptic encephalopathy.

Epilepsia·2026
Same author

Microinvasive, off-pump, transventricular neochordae implantation in recurrent mitral valve regurgitation after open heart surgical repair.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Septins buffer actomyosin forces to protect the nucleus from genotoxic mechanical stress.

bioRxiv : the preprint server for biology·2026
Same author

Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism.

Cell reports·2025

Inhibition of SMC1 protein triggers fragile site expression, a key step in cancer development. This occurs via an ATR-dependent pathway that prevents replication fork collapse, highlighting a novel mechanism in genome instability.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Common fragile sites are implicated in cancer, but their underlying molecular mechanisms remain unclear.
  • Understanding fragile sites is crucial for elucidating pathways leading to neoplastic transformation.

Purpose of the Study:

  • To investigate the role of SMC1 protein in fragile site expression and genome stability.
  • To elucidate the molecular pathways, particularly ATR-dependent mechanisms, involved in preventing replication fork collapse at fragile sites.

Main Methods:

  • RNA interference (RNAi) to inhibit SMC1 expression.
  • Analysis of normal and ATM/ATR-deficient cell lines.
  • Immunofluorescence staining for gamma-H2AX to detect DNA double-strand breaks.
  • Treatment with aphidicolin to induce replication stress.

Related Experiment Videos

Main Results:

  • SMC1 inhibition by RNAi induced fragile site expression.
  • SMC1's role in preventing stalled replication fork collapse is dependent on ATR.
  • Increased gamma-H2AX foci, indicative of double-strand breaks, were observed after aphidicolin and/or RNAi-SMC1 treatment.

Conclusions:

  • Fragile sites may arise from unrepaired DNA double-strand breaks due to prolonged replication stalling, managed by the ATR/SMC1 axis.
  • In vivo, replication blocks can lead to mitotic entry with genome assembly defects, potentially causing neoplastic transformation.
  • The ATR/SMC1 pathway is critical for maintaining genome integrity during replication stress.